CVS Health named one of the ‘World’s Most Admired’ companies
WOONSOCKET, R.I. — Fortune magazine on Thursday named CVS Health one of the “World’s Most Admired” companies. CVS was honored as No. 45 on the corporate rankings list, No. 1 in the Health Care: Pharmacy and Other Services category.
"We are incredibly proud to receive this recognition from Fortune," said Larry J. Merlo, CVS Health President and CEO. "This distinguished ranking is a direct reflection of the outstanding talent and innovation at CVS Health, as well as the passion of our 240,000 colleagues who work each day to fulfill our purpose of helping people on their path to better health."
Fortune’s World's Most Admired Companies list is based on company surveys and peer ratings from senior executives, directors and analysts. Ranking attributes range from innovativeness and quality of products to the retention of talented people and responsibility to the community and the environment.
On the drug store-related retail front, Walmart and Target also made the list, ranking No. 42 and No. 44, respectively.
NY Post: Walgreens-Rite Aid deal to be approved in 2 to 4 weeks
WASHINGTON — The Federal Trade Commission is expected to approve Walgreens’s acquisition of Rite Aid in the next two to four weeks, reported the New York Post, citing two sources close to the situation.
The major sticking point was reportedly the number of Rite Aid stores that need to be divested to Fred’s Pharmacy. The FTC gave “pushback” regarding the initial plan to divest 865 stores to Fred’s, but now that Walgreens and Rite Aid have agreed to divest up to 1,200 stores, as well improved the quality of stores to be divested, the FTC is much more likely to approve the deal.
As for the two-to-four-week timeframe, the Post reported Debbie Feinstein, bureau of competition director for the FTC, wants to get the deal approved before she resigns, expected to be “within weeks.”
Walgreens will pay Rite Aid shareholders between $6.50 and $7 per share once the deal closes, based upon the number of stores that need to be divested.
Fred’s Pharmacy has pledged to purchase all of the divested stores.
Walgreens Flu Index identifies top 3 states with flu, and 2 states where flu is gaining
DEERFIELD, Ill. — Oklahoma, Texas and Mississippi are experiencing the greatest amount of flu activity, though the greatest gains in flu activity happened in Tennessee and North Carolina, according to the latest Walgreens Flu Index for the week of Feb. 12.
This week, the top 10 markets relative to flu activity are:
- Harlingen-Weslaco-Brownsville-McAllen, Texas;
- Corpus Christi, Texas;
- Oklahoma City;
- Tyler-Longview (Lufkin & Nacogdoches), Texas;
- Dallas-Ft. Worth, Texas;
- Ft. Smith-Fayetteville-Springdale-Rogers, Ark.;
- Chattanooga, Tenn.;
- Tulsa, Okla.;
- Greenville-New Bern-Washington, N.C.; and
- Lafayette, La.
For the week of Feb. 12, the top 10 markets in terms of flu activity gains are:
- Chattanooga, Tenn.;
- Greenville-New Bern-Washington, N.C.;
- Cedar Rapids-Waterloo-Iowa City & Dubuque, Iowa;
- Tri-Cities, Tenn.-Va.;
- San Antonio;
- Oklahoma City;
- Greensboro-High Point-Winston Salem, N.C.;
- Raleigh-Durham (Fayetteville), N.C.;
- Ft. Smith-Fayetteville-Springdale-Rogers, Ark.; and
- Shreveport, La.
The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country.
The Flu Index shows which populations are experiencing the most incidences of influenza each week based on Index methodology. The data does not measure actual levels or severity of flu activity. The data is analyzed at state and geographic market levels to measure absolute impact and incremental change of antiviral medications on a per store average basis, and does not include markets in which Walgreens has fewer than 10 retail locations.